/Companies

Tubulis GmbH

acquired by Gilead Sciences

Planegg-Martinsried, DE · 15 known investors

Find your way into Tubulis GmbH

Sign up to see every warm intro you have to Tubulis GmbH

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tubulis GmbH team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics. The company operates in the biotech/oncology drug development industry, with sites in Munich, Cambridge (MA), and Lausanne.

Founders & leadership

DSDominik Schumacher
Dominik SchumacherCo-founder & CEO
JH
Jonas Helma-SmetsCo-founder & Chief Scientific Officer
CH
Christian HackenbergerScientific Co-founder

Investors · 15

Apollo Health VenturesreportedBerlin

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Tubulis GmbH went on to found or lead other companies.

Related companies · 1

Companies working in the same space as Tubulis GmbH.

Frequently asked questions

What does Tubulis GmbH do?
Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics. The company operates in the biotech/oncology drug development industry, with sites in Munich, Cambridge (MA), and Lausanne.
Who founded Tubulis GmbH?
Tubulis GmbH was founded by Dominik Schumacher.
Who are Tubulis GmbH's investors?
Tubulis GmbH's investors include Andera Partners, BioMedPartners, EQT Life Sciences, NexTech Ventures, Ascenta Capital, Bayern Kapital, coparion, Frazier Life Sciences and 7 more.
Who acquired Tubulis GmbH?
Tubulis GmbH was acquired by Gilead Sciences.
Where is Tubulis GmbH headquartered?
Tubulis GmbH is headquartered in Planegg-Martinsried, DE.